Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T23:46:31.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    An NIH-wide notice about the website transition and terminology was added. The site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.7%
    Check dated 2026-10-20T23:51:00.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T00:12:05.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Adds the latest revision tag v3.7.0 to the study history and removes the older v3.6.6, updating the historical record of revisions.
    Difference
    0.1%
    Check dated 2026-09-15T23:49:31.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, reflecting a software update to the record history interface.
    Difference
    0.1%
    Check dated 2026-09-01T19:41:43.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The history shows a new revision entry v3.6.5 added, replacing the previous v3.6.4, indicating a minor update to the record's revision history.
    Difference
    0.1%
    Check dated 2026-08-11T15:24:42.000Z thumbnail image

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.